The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic DiseaseModifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry:  A Danish Nationwide Nested Case-Control Study in the DANBIO Registry

Sabine Sparre  Dieperink; Bente Glintborg; Frank Mehnert; Mette Nørgaard; Louise Bruun Oestergaard; Thomas Benfield; Christian Torp-Pedersen; Andreas Petersen; Merete Lund Hetland

The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic DiseaseModifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry

Sabine Sparre Dieperink, Bente Glintborg, Frank Mehnert, Mette Nørgaard, Louise Bruun Oestergaard, Thomas Benfield, Christian Torp-Pedersen, Andreas Petersen, Merete Lund Hetland

Abstract

Background/Purpose:
Staphylococcus aureus bacteremia (SAB) has high mortality. We have previously identified an approximately doubled risk in patients with rheumatoid arthritis (RA), but the role of anti-rheumatic treatments and disease activity remains disputed

Original language	English
Publication date	2022
Publication status	Published - 2022
Event	ACR 2022 - Philadelphia Duration: 10 Nov 2022 → 14 Nov 2022

Conference

Conference	ACR 2022
City	Philadelphia
Period	10/11/2022 → 14/11/2022

Fingerprint

Dive into the research topics of 'The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic DiseaseModifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry'. Together they form a unique fingerprint.

Cite this

Dieperink, S. S., Glintborg, B., Mehnert, F., Nørgaard, M., Oestergaard, L. B., Benfield, T., Torp-Pedersen, C., Petersen, A., & Hetland, M. L. (2022). The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic DiseaseModifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry. Arthritis & Reumatology Vol. 74, number S9, p. 3868. Abstract from ACR 2022, Philadelphia.

The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic DiseaseModifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry. / Dieperink, Sabine Sparre ; Glintborg, Bente; Mehnert, Frank et al.
2022. Arthritis & Reumatology Vol. 74, number S9, p. 3868 Abstract from ACR 2022, Philadelphia.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Dieperink, SS , Glintborg, B, Mehnert, F, Nørgaard, M, Oestergaard, LB, Benfield, T, Torp-Pedersen, C, Petersen, A & Hetland, ML 2022, 'The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic DiseaseModifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry', ACR 2022, Philadelphia, 10/11/2022 - 14/11/2022 pp. Arthritis & Reumatology Vol. 74, number S9, p. 3868.

Dieperink SS , Glintborg B, Mehnert F, Nørgaard M, Oestergaard LB, Benfield T et al.. The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic DiseaseModifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry. 2022. Abstract from ACR 2022, Philadelphia.

Dieperink, Sabine Sparre ; Glintborg, Bente ; Mehnert, Frank et al. / The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic DiseaseModifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry : A Danish Nationwide Nested Case-Control Study in the DANBIO Registry. Abstract from ACR 2022, Philadelphia.

@conference{f4eaebfa49d140a4889c08529f6ecb43,

title = "The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic DiseaseModifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry",

abstract = "Background/Purpose: Staphylococcus aureus bacteremia (SAB) has high mortality. We have previously identified an approximately doubled risk in patients with rheumatoid arthritis (RA), but the role of anti-rheumatic treatments and disease activity remains disputed",

author = "Dieperink, {Sabine Sparre} and Bente Glintborg and Frank Mehnert and Mette N{\o}rgaard and Oestergaard, {Louise Bruun} and Thomas Benfield and Christian Torp-Pedersen and Andreas Petersen and Hetland, {Merete Lund}",

note = "COPECARE; ACR 2022 ; Conference date: 10-11-2022 Through 14-11-2022",

year = "2022",

language = "English",

pages = "Arthritis & Reumatology Vol. 74, number S9, p. 3868",

}

TY - ABST

T1 - The Increased Risk of Staphylococcus Aureus Bacteremia in Rheumatoid Arthritis – What Is the Impact of Glucocorticoids, Biologic DiseaseModifying Anti-Rheumatic Drugs and Disease Activity: A Danish Nationwide Nested Case-Control Study in the DANBIO Registry

T2 - ACR 2022

AU - Dieperink, Sabine Sparre

AU - Glintborg, Bente

AU - Mehnert, Frank

AU - Nørgaard, Mette

AU - Oestergaard, Louise Bruun

AU - Benfield, Thomas

AU - Torp-Pedersen, Christian

AU - Petersen, Andreas

AU - Hetland, Merete Lund

N1 - COPECARE

PY - 2022

Y1 - 2022

N2 - Background/Purpose: Staphylococcus aureus bacteremia (SAB) has high mortality. We have previously identified an approximately doubled risk in patients with rheumatoid arthritis (RA), but the role of anti-rheumatic treatments and disease activity remains disputed

AB - Background/Purpose: Staphylococcus aureus bacteremia (SAB) has high mortality. We have previously identified an approximately doubled risk in patients with rheumatoid arthritis (RA), but the role of anti-rheumatic treatments and disease activity remains disputed

M3 - Conference abstract for conference

SP - Arthritis & Reumatology Vol. 74, number S9, p. 3868

Y2 - 10 November 2022 through 14 November 2022

ER -